Cost-effectiveness of posaconazole in private and public Brazilian hospitals.

CONCLUSIONS: In Brazil posaconazole is cost-effective, and should be considered for the prophylaxis of patients with AMD/myelodysplasia (AML/MDS) undergoing chemotherapy.
PMID: 29605496 [PubMed - as supplied by publisher]

Source: Revista Iberoamericana de Micologia - March 28, 2018 Category: Biology Authors: Tuon FFB, Lino Florencio K, da Cunha CA, Lopes Rocha JL Tags: Rev Iberoam Micol Source Type: research